Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial

Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the ADXS-NEO study is displayed, including its terminated status, study design, participant criteria, locations, and measures. The page also includes study history, publications, and related drug and disease information.
    Difference
    57%
    Check dated 2026-11-08T15:06:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:56:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:19:58.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T20:38:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-11T20:37:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, indicating restricted access. The changes include the error content and site chrome, signaling an access issue rather than substantive content updates.
    Difference
    20%
    Check dated 2026-09-20T19:53:36.000Z thumbnail image

Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.